media – Page 596 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

New imaging study reveals how saturated fatty acids damage cells

While doctors, nutritionists and researchers have known for a long time that saturated fats contribute to some of the leading causes of death in the United States, they haven't been able to determine how or why excess saturated fats, such as those released from lard, are toxic to cells and cause a wide variety of lipid-related diseases, while unsaturated fats, such as those from fish and olive oil, can be protective.
- Source: medicalxpress
- 596
- December 4, 2017
Researches saturated fat
Ddu College–China’s Import and Export Market Report of Antiallergic Drugs

Allergies, also known as allergic diseases, are a number of conditions caused by hypersensitivity of the immune system to something in the environment that usually causes little or no problems to most people. These diseases include hay fever, food allergies, atopic dermatitis, allergic asthma and anaphylaxis. Symptoms may include red eyes, an itchy rash, sneezing and a runny nose, shortness of breath or swelling. Food intolerances and food poisoning are separate conditions.
- Source: Ddu
- 5,898
- December 1, 2017
Allergies antiallergic drugs hypersensitivity Market Reports
When PSA Is 4-10, phi Test Helps With Biopsy Decision

The Prostate Health Index (phi) (Beckman Coulter) significantly changes urologists' opinions about whether men with certain results on prostate-specific antigen (PSA) screening should or should not undergo a prostate biopsy to assess for cancer, according to new observational research.
- Source: medscape
- 823
- December 1, 2017
cancer PSA Researches
Linda Healthcare Infuses A.I. and Blockchain to build Crypto Health Insurance

Over the past few years, more and more people have recognized the power of the blockchain to transform industries. In the over regulated, bureaucratic healthcare market, this is especially the case. Blockchain technology and innovative companies have the ability to revolutionize this market, create tremendous value, improve patient outcomes, create new treatments and pharmaceuticals while creating incredible companies that richly reward founders and management. Linda Health is one such company that is changing the market place with the blockchain. They have created a virtual medical assistant that is changing lives.
- Source: blockchainhealthcarereview
- 735
- December 1, 2017
blockchain ICO Researches
Blood test offers new way to monitor disease activity

Monitoring disease activity in individuals with multiple sclerosis, either to predict flare-ups or to check treatment response, might be done with a simple blood test that measures levels of a nerve protein, according to a new study from Norway.
- Source: medicalnewstoday
- 614
- December 1, 2017
immune Market Views multiple sclerosis nerves
China’s success–first human implantation of a retrievable transcatheter aortic valve

Prof. Wang Jian'an, president of SAHZU, announced that China has completed its first successful human implantation of a retrievable transcatheter aortic valve.
- Source: biospectrumasia
- 508
- December 1, 2017
aortic valve cardiac implantation Market Views transcatheter
Amgen pulls ahead in sprint towards CGRP approval with promising PhIII migraine data

The frontrunner in the race to commercialize CGRP migraine medications just picked up some added momentum. Amgen $AMGN has published promising Phase III data that might lend to its approval, keeping the company — and its partner Novartis — ahead of its many competitors in the crowded space.
- Source: Endpts
- 511
- December 1, 2017
Aimovig Clinical Trials Phase
Fully Functioning Artificial Human Heart Muscle Developed

Duke University researchers say they have created an artificial human heart muscle large enough to patch over damage seen in patients who have suffered a heart attack. The advance takes a major step toward the end goal of repairing dead heart muscle in human patients, the team adds.
- Source: Genengnews
- 442
- December 1, 2017
artificial heart Researches
metaLinear Secures 255K Pound Seed Investment for Targeted Antibacterial Research

MetaLinear is a start-up biotechnology company founded in 2017, focused on the identification and validation of new drug targets for difficult to treat bacterial infections. The new investment was secured from the BioCity Group Ltd, who manage the Alderley Park Ventures (APV) fund and Catapult Ventures, who manage the Greater Manchester and Cheshire (GM&C) Life Sciences Fund. Both funds look to back innovative, high-technology companies providing much needed early stage finance.
- Source: biocity.co.uk;
- 476
- December 1, 2017
bacterial infections Market Views new drug
New technique to model transplantation of the human liver

Novel model for ex situ reperfusion of the human liver following subnormothermic machine perfusion.
- Source: World Scientific
- 415
- November 30, 2017
liver transplantation Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.